Listed

Taysha Gene Therapies, Inc.

TSHANasdaqCIK 1806310HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$47.3m, Q2 FY2026
Net income−$46.6m, Q2 FY2026
Taysha Gene Therapies, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m4.7Revenue, Q3 FY2023, three months to 2023-09-30$4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure3.6Revenue, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-26, accession 0000950170-25-027348. Derived: 12-month figure less the 9-month figure.Report this figure3.4Revenue, Q1 FY2024, three months to 2024-03-31$3.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure1.1Revenue, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure1.8Revenue, Q3 FY2024, three months to 2024-09-30$1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure2.0Revenue, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure2.3Revenue, Q1 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure2.0Revenue, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure5.5Revenue, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Research and development$m11.8Research and development, Q3 FY2023, three months to 2023-09-30$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure12.7Research and development, Q4 FY2023, three months to 2023-12-31$12.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-26, accession 0000950170-25-027348. Derived: 12-month figure less the 9-month figure.Report this figure20.7Research and development, Q1 FY2024, three months to 2024-03-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure15.1Research and development, Q2 FY2024, three months to 2024-06-30$15.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure14.9Research and development, Q3 FY2024, three months to 2024-09-30$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure15.3Research and development, Q4 FY2024, three months to 2024-12-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure15.6Research and development, Q1 FY2025, three months to 2025-03-31$15.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure20.1Research and development, Q2 FY2025, three months to 2025-06-30$20.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure25.7Research and development, Q3 FY2025, three months to 2025-09-30$25.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure25.0Research and development, Q4 FY2025, three months to 2025-12-31$25.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure33.8Research and development, Q1 FY2026, three months to 2026-03-31$33.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure38.6Research and development, Q2 FY2026, three months to 2026-06-30$38.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Operating income$m(16.3)Operating income, Q3 FY2023, three months to 2023-09-30−$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure(16.2)Operating income, Q4 FY2023, three months to 2023-12-31−$16.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-26, accession 0000950170-25-027348. Derived: 12-month figure less the 9-month figure.Report this figure(24.3)Operating income, Q1 FY2024, three months to 2024-03-31−$24.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure(21.3)Operating income, Q2 FY2024, three months to 2024-06-30−$21.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure(25.9)Operating income, Q3 FY2024, three months to 2024-09-30−$25.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure(19.9)Operating income, Q4 FY2024, three months to 2024-12-31−$19.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure(21.4)Operating income, Q1 FY2025, three months to 2025-03-31−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(26.8)Operating income, Q2 FY2025, three months to 2025-06-30−$26.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure(34.0)Operating income, Q3 FY2025, three months to 2025-09-30−$34.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure(28.3)Operating income, Q4 FY2025, three months to 2025-12-31−$28.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure(43.5)Operating income, Q1 FY2026, three months to 2026-03-31−$43.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(47.3)Operating income, Q2 FY2026, three months to 2026-06-30−$47.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Interest expense$m1.5Interest expense, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure0.7Interest expense, Q4 FY2023, three months to 2023-12-31$713.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-19, accession 0000950170-24-033484. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$29.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$27.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$24.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$22.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$19.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$17.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$15.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$12.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$9.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$6.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-14, accession 0000950170-23-063734. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-19, accession 0000950170-24-033484. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-12, accession 0000950170-24-095082. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0000950170-24-126416. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-107010. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-263506. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-344610. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(117)Net income, Q3 FY2023, three months to 2023-09-30−$117.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure47.7Net income, Q4 FY2023, three months to 2023-12-31$47.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-26, accession 0000950170-25-027348. Derived: 12-month figure less the 9-month figure.Report this figure(24.1)Net income, Q1 FY2024, three months to 2024-03-31−$24.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure(20.9)Net income, Q2 FY2024, three months to 2024-06-30−$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure(25.5)Net income, Q3 FY2024, three months to 2024-09-30−$25.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure(18.8)Net income, Q4 FY2024, three months to 2024-12-31−$18.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure(21.5)Net income, Q1 FY2025, three months to 2025-03-31−$21.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(26.9)Net income, Q2 FY2025, three months to 2025-06-30−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure(32.7)Net income, Q3 FY2025, three months to 2025-09-30−$32.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure(27.9)Net income, Q4 FY2025, three months to 2025-12-31−$27.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure(42.4)Net income, Q1 FY2026, three months to 2026-03-31−$42.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(46.6)Net income, Q2 FY2026, three months to 2026-06-30−$46.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Diluted EPS$ per share(0.93)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure(0.09)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure(0.10)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(0.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure(0.09)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figurenot reported(0.12)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(0.13)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Basic EPS$ per share(0.93)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figurenot reported(0.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure(0.09)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure(0.10)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figurenot reported(0.08)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure(0.09)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figurenot reported(0.12)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(0.13)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure

Balance sheet

Cash and equivalents$455.4m, Q2 FY2026
Long-term debt$49.3m, Q2 FY2026
Shareholders' equity$387.3m, Q2 FY2026
Taysha Gene Therapies, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m164Cash and equivalents, Q3 FY2023, at 2023-09-30$164.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure144Cash and equivalents, FY2023, at 2023-12-31$143.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0000950170-25-027348.Report this figure124Cash and equivalents, Q1 FY2024, at 2024-03-31$124.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure173Cash and equivalents, Q2 FY2024, at 2024-06-30$172.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure158Cash and equivalents, Q3 FY2024, at 2024-09-30$157.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure139Cash and equivalents, FY2024, at 2024-12-31$139.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure117Cash and equivalents, Q1 FY2025, at 2025-03-31$116.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure313Cash and equivalents, Q2 FY2025, at 2025-06-30$312.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure297Cash and equivalents, Q3 FY2025, at 2025-09-30$297.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure320Cash and equivalents, FY2025, at 2025-12-31$319.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure277Cash and equivalents, Q1 FY2026, at 2026-03-31$276.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure455Cash and equivalents, Q2 FY2026, at 2026-06-30$455.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Current assets$m172Current assets, Q3 FY2023, at 2023-09-30$171.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure150Current assets, FY2023, at 2023-12-31$149.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0000950170-25-027348.Report this figure131Current assets, Q1 FY2024, at 2024-03-31$130.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure178Current assets, Q2 FY2024, at 2024-06-30$178.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure162Current assets, Q3 FY2024, at 2024-09-30$161.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure142Current assets, FY2024, at 2024-12-31$142.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure121Current assets, Q1 FY2025, at 2025-03-31$120.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure316Current assets, Q2 FY2025, at 2025-06-30$316.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure300Current assets, Q3 FY2025, at 2025-09-30$300.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure325Current assets, FY2025, at 2025-12-31$324.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure282Current assets, Q1 FY2026, at 2026-03-31$282.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure461Current assets, Q2 FY2026, at 2026-06-30$461.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Total assets$m196Total assets, Q3 FY2023, at 2023-09-30$195.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure173Total assets, FY2023, at 2023-12-31$172.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0000950170-25-027348.Report this figure153Total assets, Q1 FY2024, at 2024-03-31$153.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure200Total assets, Q2 FY2024, at 2024-06-30$200.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure180Total assets, Q3 FY2024, at 2024-09-30$180.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure160Total assets, FY2024, at 2024-12-31$160.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure138Total assets, Q1 FY2025, at 2025-03-31$138.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure333Total assets, Q2 FY2025, at 2025-06-30$333.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure317Total assets, Q3 FY2025, at 2025-09-30$316.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure343Total assets, FY2025, at 2025-12-31$343.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure300Total assets, Q1 FY2026, at 2026-03-31$300.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure470Total assets, Q2 FY2026, at 2026-06-30$470.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Current liabilities$m180Current liabilities, Q3 FY2023, at 2023-09-30$180.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure36.8Current liabilities, FY2023, at 2023-12-31$36.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0000950170-25-027348.Report this figure38.6Current liabilities, Q1 FY2024, at 2024-03-31$38.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure34.2Current liabilities, Q2 FY2024, at 2024-06-30$34.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure29.3Current liabilities, Q3 FY2024, at 2024-09-30$29.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure26.2Current liabilities, FY2024, at 2024-12-31$26.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure22.6Current liabilities, Q1 FY2025, at 2025-03-31$22.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure25.3Current liabilities, Q2 FY2025, at 2025-06-30$25.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure28.6Current liabilities, Q3 FY2025, at 2025-09-30$28.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure26.6Current liabilities, FY2025, at 2025-12-31$26.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure20.1Current liabilities, Q1 FY2026, at 2026-03-31$20.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure26.0Current liabilities, Q2 FY2026, at 2026-06-30$26.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Total liabilities$m245Total liabilities, Q3 FY2023, at 2023-09-30$244.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure97.8Total liabilities, FY2023, at 2023-12-31$97.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0000950170-25-027348.Report this figure99.2Total liabilities, Q1 FY2024, at 2024-03-31$99.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure91.5Total liabilities, Q2 FY2024, at 2024-06-30$91.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure91.4Total liabilities, Q3 FY2024, at 2024-09-30$91.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure88.8Total liabilities, FY2024, at 2024-12-31$88.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure83.3Total liabilities, Q1 FY2025, at 2025-03-31$83.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure84.6Total liabilities, Q2 FY2025, at 2025-06-30$84.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure97.6Total liabilities, Q3 FY2025, at 2025-09-30$97.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure96.4Total liabilities, FY2025, at 2025-12-31$96.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure88.4Total liabilities, Q1 FY2026, at 2026-03-31$88.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure83.2Total liabilities, Q2 FY2026, at 2026-06-30$83.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Long-term debt$m38.5Long-term debt, Q3 FY2023, at 2023-09-30$38.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure40.5Long-term debt, FY2023, at 2023-12-31$40.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-26, accession 0000950170-25-027348.Report this figure40.5Long-term debt, Q1 FY2024, at 2024-03-31$40.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure37.8Long-term debt, Q2 FY2024, at 2024-06-30$37.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure43.0Long-term debt, Q3 FY2024, at 2024-09-30$43.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure43.9Long-term debt, FY2024, at 2024-12-31$43.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure42.5Long-term debt, Q1 FY2025, at 2025-03-31$42.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure41.1Long-term debt, Q2 FY2025, at 2025-06-30$41.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure50.9Long-term debt, Q3 FY2025, at 2025-09-30$50.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure50.1Long-term debt, FY2025, at 2025-12-31$50.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure49.0Long-term debt, Q1 FY2026, at 2026-03-31$49.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure49.3Long-term debt, Q2 FY2026, at 2026-06-30$49.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure
Shareholders' equity$m(49.1)Shareholders' equity, Q3 FY2023, at 2023-09-30−$49.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure74.9Shareholders' equity, FY2023, at 2023-12-31$74.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-115202.Report this figure53.8Shareholders' equity, Q1 FY2024, at 2024-03-31$53.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure109Shareholders' equity, Q2 FY2024, at 2024-06-30$108.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure88.8Shareholders' equity, Q3 FY2024, at 2024-09-30$88.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure71.5Shareholders' equity, FY2024, at 2024-12-31$71.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure55.1Shareholders' equity, Q1 FY2025, at 2025-03-31$55.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure249Shareholders' equity, Q2 FY2025, at 2025-06-30$248.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure219Shareholders' equity, Q3 FY2025, at 2025-09-30$219.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure247Shareholders' equity, FY2025, at 2025-12-31$246.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure212Shareholders' equity, Q1 FY2026, at 2026-03-31$211.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure387Shareholders' equity, Q2 FY2026, at 2026-06-30$387.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure

Cash flow

Operating cash flow−$40.4m, Q2 FY2026
Capital expenditure−$1.0k, Q2 FY2026
Taysha Gene Therapies, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-126416. Derived: 9-month figure less the 6-month figure.Report this figure(16.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-26, accession 0000950170-25-027348. Derived: 12-month figure less the 9-month figure.Report this figure(19.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure(21.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107010. Derived: 6-month figure less the 3-month figure.Report this figure(21.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263506. Derived: 9-month figure less the 6-month figure.Report this figure(18.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure(22.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$22.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(20.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$20.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344610. Derived: 6-month figure less the 3-month figure.Report this figure(24.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$24.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263506. Derived: 9-month figure less the 6-month figure.Report this figure(26.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$26.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure(40.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$40.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(40.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$40.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344610. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-126416. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-26, accession 0000950170-25-027348. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$201.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107010. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-263506. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$378.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344610. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-263506. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2025, three months to 2025-12-31$250.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115202. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure(0.0)Capital expenditure, Q2 FY2026, three months to 2026-06-30−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344610. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)369.04m, Q2 FY2026
Taysha Gene Therapies, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares40.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3040,937,808 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0000950170-23-063734.Report this figure63.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3163,260,905 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059555.Report this figure64.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3064,244,531 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095082.Report this figure126Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30125,700,799 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-126416.Report this figure231Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31231,249,344 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-072036.Report this figure233Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30232,821,553 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107010.Report this figure268Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30267,824,045 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure269Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31269,306,331 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure298Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30297,988,978 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure353Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30353,309,524 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263506.Report this figure367Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31366,632,827 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-207666.Report this figure369Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30369,044,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure

Shares outstanding: 325.83mShares outstanding, period not labelled, at 2026-08-11325,833,545 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344610.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.